GHRP-2 vs Ipamorelin
A detailed comparison to help you understand the differences and choose the right peptide for your research.
GHRP-2 and Ipamorelin represent different philosophies in GH secretagogue development. GHRP-2 offers robust GH release with some hormonal effects, while Ipamorelin was developed for maximum selectivity. This comparison helps you understand the tradeoffs between potency and clean hormone profiles.
Quick Comparison
Key Similarities
- Both are growth hormone releasing peptides
- Both work through ghrelin receptor
- Both use similar dosing (100-300 mcg)
- Both synergize with GHRH peptides
- Both require empty stomach dosing
- Both produce pulsatile GH patterns
Key Differences
- GHRP-2 is more potent but less selective
- Ipamorelin doesn't affect cortisol or prolactin
- GHRP-2 causes more hunger increase
- Ipamorelin has a 'cleaner' overall profile
- GHRP-2 may be better for maximum GH goals
- Ipamorelin preferred for long-term use
When to Choose Each
Choose GHRP-2
Choose GHRP-2 when maximum GH release is the priority and you can tolerate moderate side effects. Good for short-term intensive protocols or when cost is a factor.
Choose Ipamorelin
Choose Ipamorelin when you want selective GH stimulation without affecting other hormones. Ideal for long-term use, cutting phases, or when a clean profile is essential.
Can You Stack Them?
Both peptides can be combined with GHRH peptides for enhanced effects. Some researchers use both in rotation—GHRP-2 for intensive phases and Ipamorelin for maintenance.
Frequently Asked Questions
References
- Raun K, et al. "Ipamorelin selectivity." Eur J Endocrinol, 1998. PMID: 9758455
Get the Complete Comparison Guide
Download our detailed comparison charts and decision framework.